Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.718073
Abstract: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder in the elderly. Systemic and topical use of glucocorticoids and immunosuppressants has been shown to be effective in most patients. However, refractory BP patients… read more here.
Keywords: strategies refractory; therapeutic strategies; bullous pemphigoid; emerging biomarkers ... See more keywords